📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. (2020)

First Author: Xie W

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.19.03114

PubMed Identifier: 32552276

Publication URI: http://europepmc.org/abstract/MED/32552276

Type: Journal Article/Review

Volume: 38

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 26

ISSN: 0732-183X